Showing results (21-30 of 835) with videos related to
Sort By:
Pageof 84
Cancer Research|December 1, 1985
Experimental metastatic ability of H-ras-transformed NIH3T3 cellsG P Bondy, S Wilson, A F ChambersJournal of Cellular Biochemistry|February 1, 1994
Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesionJ W Xuan, C Hota, A F ChambersJournal of the National Cancer Institute|June 1, 1988
Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ras-transformed NIH 3T3 cellsS A Hill, S Wilson, A F ChambersCancer Research|February 1, 1993
Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and lamininA F Chambers, C Hota, C W PrinceInvasion & Metastasis|January 1, 1990
ras-transformed NIH 3T3 cell lines, selected for metastatic ability in chick embryos, have increased proportions of p21-expressing cells and are metastatic in nude miceA F Chambers, G H Denhardt, S M WilsonSomatic Cell and Molecular Genetics|January 1, 1990
Some ras-transformed cells have increased radiosensitivity and decreased repair of sublethal radiation damageJ F Harris, A F Chambers, A S TamSomatic Cell and Molecular Genetics|May 1, 1988
Rates of generation of methotrexate-resistant variants in cells temperature-sensitive for malignant transformationA F Chambers, J F Harris, J S GrundyCancer Research|June 15, 1996
Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absence of a p53-dependent cell cycle arrest [corrected]C L Nutt, A F Chambers, J G CairncrossClinical & Experimental Metastasis|September 1, 1990
ras transfection and expression does not induce progression from tumorigenicity to metastatic ability in mouse LTA cellsA B Tuck, S M Wilson, A F ChambersClinical & Experimental Metastasis|March 1, 1991
Modulation of clonal progression in B16F1 melanoma cellsJ F Harris, A F Chambers, A S TamPageof 84